Cullinan Therapeutics, Inc. (CGEM)

CIK 1789972 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cullinan Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 202640001193125-26-387381
Sep 8, 20261440001950047-26-009190
Aug 14, 2026SCHEDULE 13G/A0000921895-26-002166
Aug 14, 2026SCHEDULE 13G0000080255-26-000574
Aug 14, 202640001193125-26-352523
Aug 13, 20261440001950047-26-008087
Aug 13, 20268-K0001193125-26-347400
Aug 7, 2026SCHEDULE 13G0000093751-26-000446
Aug 6, 20268-K0001193125-26-336700
Aug 6, 202610-Q0001193125-26-336717
Jul 7, 202640001193125-26-297605
Jul 6, 20261440001950047-26-006865
Jul 2, 202640001193125-26-294863
Jul 2, 202640001193125-26-294869
Jun 18, 202640001193125-26-276059
Jun 18, 202640001193125-26-276056
Jun 18, 202640001193125-26-276057
Jun 18, 202640001193125-26-276060
Jun 18, 202640001193125-26-276055
Jun 18, 202640001193125-26-276054
Jun 16, 20268-K0001193125-26-272890
Jun 10, 20268-K0001193125-26-264916
Jun 8, 20268-K0001193125-26-260640
May 18, 20268-K0001193125-26-229173
May 15, 2026SCHEDULE 13G/A0000921895-26-001387